Phase 1 Study in Diabetes Mellitus(Fasting)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 17, 2024

Primary Completion Date

February 15, 2024

Study Completion Date

March 18, 2024

Conditions

DiabetesDiabetes Mellitus

Interventions

DRUG

HUC2-344

per oral

DRUG

HUC2-344-R1, HUC2-344-R2

per oral

Trial Locations (1)

Huons, Seoul

All Listed Sponsors

lead

Huons Co., Ltd.

INDUSTRY

NCT06552182 - Phase 1 Study in Diabetes Mellitus(Fasting) | Biotech Hunter | Biotech Hunter